News & Events
The UK MS Society met up with Brooklyn rapper and record producer Masta Ace to talk about…
EMA conducts safety review of alemtuzumab (Lemtrada)
FDA approves cladribine for people with relapsing forms of MS and active secondary progressive MS
FDA approves the drug Siponimod, to treat people with active secondary progressive MS
A new study examined different disease modifying therapies and their ability to slow the onset of secondary…
MS affects at least twice as many more women than men, and it often strikes at an…
976 chemicals were screened to assess their impact on MS.
A trial has compared a cancer chemotherapy to MS treatments, but further research is needed to understand…
We have collaborated with our members to adapt an animation that addresses some of the challenges of…
Multiple Sclerosis Spain has launched a new illustration with tips to help improve quality of life for…
Against MS is the DIY fundraising initiative for the MS International Federation because as the leaders of…
Martin Stevens is awarded for his services to people with MS